USPTO serial 79312728
AMANO WORLD NO.1 SPECIALITY ENZYME PRODUCER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- WILSON, MARYNELLE WEST
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AMANO WORLD NO.1 SPECIALITY ENZYME PRODUCER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John E. Lyhus
John E. Lyhus Fitch, Even, Tabin & Flannery LLPSuite 2100120 S. LaSalle StreetChicago, IL 60603Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for industrial purposes; enzymes for scientific purposes; enzymes for use in the food industry; enzymes for scientific and research purposes; enzyme preparations for use in the food industry; enzyme preparations for industrial purposes; reagents for research purposes; industrial chemicals | ACTIVE | — |
| 005 | Enzymes for medical purposes; enzyme preparations for medical purposes; enzyme preparations for medical use, namely, for use in the treatment of dyspepsia, intolerance, colitis, autism disorder, and brain function disorder; enzyme preparations for veterinary purposes; diagnostic enzyme preparations for medical and veterinary purposes; medicines for the treatment of gastrointestinal diseases; reagents for medical use; diagnostic reagents for medical use; veterinary diagnostic reagents; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; reagent paper for medical purposes; dietary supplements for human consumption; enzyme dietary supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, powdered milk for babies; food for babies; lacteal flour for babies; dietary supplements for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AMANO ENZYME INC.
- Other trademarks owned by AMANO ENZYME INC.
- Other trademarks owned by AMANO ENZYME INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named AMANO WORLD NO.1 SPECIALITY ENZYME PRODUCER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 27, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 28, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 5, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 2, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 10, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |